Home Cerulean Pharma

Cerulean Pharma

acquired
IPO Delisting
Developer of Novel Nanotechnology Therapeutics
Basic
Enterprise Profile

Basic Information

Cerulean Pharma Inc. is a privately held biopharmaceutical company focused on developing novel nanotechnology-based therapeutics in the fields of oncology, cardiovascular, autoimmune, and inflammatory diseases. The company’s products are related to fertility, vaginal health, and contraception. Ovaprene, a product designed by the company, provides multi-week contraceptive protection without the use of hormones.
Cerulean Pharma Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2006
--
info@Ceruleanrx.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
Obstetrics and Gynecology Tumor Cardiovascular Disease Immune System Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs Nanotechnology